James Loughman
CEO
Ocumetra
The startup develops a digital healthcare platform that provides evidence-based clinical decision support tools for eyecare professionals, making complex clinical data accessible and actionable. This platform enhances communication between practitioners and patients, ultimately improving health outcomes for individuals at risk of blindness or myopia.
- Artificial Intelligence
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$3.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Ian Flitcroft
CIO
Product
Problem
Managing myopia, or nearsightedness, in children requires frequent monitoring and effective communication with parents to ensure treatment adherence and optimal outcomes. Many eyecare professionals lack efficient tools to track myopia progression, analyze biometric data, and clearly convey treatment benefits to parents, leading to suboptimal management and potential long-term vision complications.
Solution
Ocumetra provides a digital healthcare platform that equips eyecare professionals with clinical decision support and communication tools to streamline myopia management. The platform integrates a database of population-representative data, enabling clinicians to compare a child's refraction and axial length to their peers, assess individual risk profiles, and project potential myopia progression. Ocumetra's mEYE® Suite offers features such as axial length estimation, centile charts, vision simulation, and treatment outcome projections to facilitate informed discussions with parents and enhance treatment uptake. By providing data-driven insights and visual aids, Ocumetra helps practitioners optimize chair time, improve patient compliance, and deliver personalized myopia management plans.
Target Audience
The primary target audience includes ophthalmologists, optometrists, and other eyecare professionals specializing in pediatric vision care and myopia management.
Features
- mEYE®Guide: Saves chair time and ensures comprehensive myopia management.
- mEYE®Gauge: Provides axial length estimation and analysis without requiring biometry equipment.
- Parent-friendly reports: Designed for instant sharing via QR code or link, demonstrating a child’s personalized myopia risk profile and potential treatment benefits.
- Centile Charts: Illustrate how a child’s vision compares to others of the same age and sex, projecting adult refraction based on centile position.
- Vision Simulator: Helps parents understand how their child sees now and how they may see as an adult without treatment.
- Treatment Benefits Visualization: Illustrates myopia progression and potential ocular health benefits of management.
- Ocular Biometric Analysis: Uses refraction, axial length, and keratometry data to illustrate the main cause of myopia in each patient.
- API Integrations: Enables integration across different devices, EHR systems, and platforms.